Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Boots offers free indemnity insurance for employees’ primary care work

Boots will offer free indemnity insurance to its pharmacists working part-time in primary care, it has told C+D.

All Boots employees are already covered by insurer Axa, the multiple explained, but this coverage does not extend to “when they are working outside of Boots in a primary care setting”.

“We will shortly be launching a new scheme with reputable insurers that allows a Boots pharmacist who wants to work one or two days a week in primary care to apply for a strong insurance policy that will cover their professional work as well,” Boots UK chief pharmacist Marc Donovan said this morning (November 2).

“Because of our very significant buying scale, we can offer this free, at no cost to our pharmacists,” he added.

“We have been trying for some time to find a way in which our pharmacists can be covered for both their work at Boots and their work in primary care, and we are pleased to say that we have found a solution,” he explained.

The multiple has already let its employees know, and will be sharing further details “in due course”, Mr Donovan said.

Employees will be able to apply for the insurance from January, and the cover “will fully meet General Pharmaceutical Council registration requirements”, he stressed.

Read C+D’s in-depth analysis of how indemnity insurance is adapting to the expanding role of pharmacists.

Have you seen your indemnity insurance change in recent years?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD005602

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel